An Interview With Selene Capodarca, Global Study Coordinator for HD-Enroll
Episode 105, Dec 07, 2023, 08:42 PM
Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Selene Capodarca. This Italian expert in pharmaceutical chemistry and technology, is the global study director for Enroll-HD, with 30,000 patients the world's largest observational study in Huntington disease.